Eyenovia Stock Price

0.00 (0.0%)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Eyenovia Inc EYEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.40 08:00:20
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
4.31 4.99 0.68 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 4.40 USD


Draw Mode:

Eyenovia Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 113.76M 25.86M 17.85M $ 2.00M $ - -0.94 -5.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 834.85k 9.40%

more financials information »

Eyenovia News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EYEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.594.904.334.69113,710-0.19-4.14%
1 Month5.255.284.334.7487,770-0.85-16.19%
3 Months5.,900-0.63-12.52%
6 Months6.647.724.275.35152,111-2.24-33.73%
1 Year3.787.722.904.90431,7490.6216.4%
3 Years5.957.721.114.56210,882-1.55-26.05%
5 Years10.0010.741.114.65184,736-5.60-56.0%

Eyenovia Description

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.